About UCSF Search UCSF UCSF Medical Center

John K. Chan, MD

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
chan_john

Director of Gynecologic Oncology, UCSF Helen Diller Family Comprehensive Cancer Center
John A. Kerner Distinguished Professorship in Gynecologic Oncology, UCSF

Phone: (415) 353-9600 (appts)
Box 1702, UCSF
San Francisco, CA 94143-1702

View on UCSF Profiles


Additional Websites


Education

University of California, Berkeley, BA, 1987-91, Molecular Cell Biology
University of California, Los Angeles, MD, 1991-95, Medicine


Professional Experience

  • 1999 - 2003
    Clinical Instructor, Department of Obstetrics and Gynecology, University of California, Irvine UC Irvine Medical Center
  • 2003 - 2007
    Assistant Professor, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Stanford University School of Medicine
  • 2007 - present
    Assistant Professor, Director of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of California, San Francisco
  • 2007 - present
    Director of Division of Gynecologic Oncology, University of California, San Francisco, CA
  • 2007 - present
    John A. Kerner Distinguished Professorship in Gynecologic Oncology

Honors & Awards

  • 1995
    School of Medicine's "Highest Honor for Compassion and Academic Excellence," UCLA School of Medicine
  • 1999
    National Cancer Institute / Gynecologic Cancer Foundation Research Fellowship (Honorary recipient)
  • 1999
    Resident Teacher of the Year, UC Irvine School of Medicine
  • 2000
    Clinical Research Fellowship Award, American Cancer Society
  • 2002
    Reproductive Scientist Development Award, National Institute of Health
  • 2004
    Outstanding Faculty Award, Dept. of Ob/Gyn, Stanford University
  • 2005
    Reproductive Scientist Development Award, (phase II) National Institute of Health
  • 2005
    Frank Lynch Essay Award, Pacific Coast Ob/Gyn Society
  • 2005
    Ted Adams poster award, Pacific Coast Ob/Gyn Society
  • 2006
    Investigator Award - Ovarian Cancer Immunotherapy - Stanford Cancer Center
  • 2006
    Investigator Award - Ovarian Cancer Population-based Program - Stanford Cancer Center
  • 2006
    Gynecologic Cancer Foundation (GCF) Research Award

Selected Publications

  1. Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013 May; 107(6):653-8.
    View on PubMed
  2. Cohen JG, Chan JK, Kapp DS. The management of small-cell carcinomas of the gynecologic tract. Curr Opin Oncol. 2012 Sep; 24(5):572-9.
    View on PubMed
  3. Cohen JG, Kiet T, Shin JY, Sherman AE, Hamilton CA, Brooks RA, Ueda SM, Chen LM, Kapp DS, Chan JK. Factors associated with publication of plenary presentations at the Society of Gynecologic Oncologists annual meeting. Gynecol Oncol. 2013 Jan; 128(1):128-31.
    View on PubMed
  4. Cohen JG, Sherman AE, Kiet TK, Kapp DS, Osann K, Chen LM, O'Sullivan PS, Chan JK. Characteristics of success in mentoring and research productivity - a case-control study of academic centers. Gynecol Oncol. 2012 Apr; 125(1):8-13.
    View on PubMed
  5. Venkat P, Chen LM, Young-Lin N, Kiet TK, Young G, Amatori D, Dasverma B, Yu X, Kapp DS, Chan JK. An economic analysis of robotic versus laparoscopic surgery for endometrial cancer: costs, charges and reimbursements to hospitals and professionals. Gynecol Oncol. 2012 Apr; 125(1):237-40.
    View on PubMed
  6. Dalton HJ, Yu X, Hu L, Kapp DS, Benjamin I, Monk BJ, Chan JK. An economic analysis of dose dense weekly paclitaxel plus carboplatin versus every-3-week paclitaxel plus carboplatin in the treatment of advanced ovarian cancer. Gynecol Oncol. 2012 Feb; 124(2):199-204.
    View on PubMed
  7. Chan JK, Sherman AE, Kapp DS, Zhang R, Osann KE, Maxwell L, Chen LM, Deshmukh H. Influence of gynecologic oncologists on the survival of patients with endometrial cancer. J Clin Oncol. 2011 Mar 1; 29(7):832-8.
    View on PubMed
  8. Cohen JG, Kapp DS, Shin JY, Urban R, Sherman AE, Chen LM, Osann K, Chan JK. Small cell carcinoma of the cervix: treatment and survival outcomes of 188 patients. Am J Obstet Gynecol. 2010 Oct; 203(4):347.e1-6.
    View on PubMed
  9. Chan JK, Tian C, Fleming GF, Monk BJ, Herzog TJ, Kapp DS, Bell J. The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: an exploratory analysis of a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):301-6.
    View on PubMed
  10. Chan JK, Tian C, Teoh D, Monk BJ, Herzog T, Kapp DS, Bell J. Survival after recurrence in early-stage high-risk epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol. 2010 Mar; 116(3):307-11.
    View on PubMed
  11. Chen LM, Weinberg VK, Chen C, Powell CB, Chen LL, Chan JK, Burkhardt DH. Perioperative outcomes comparing patient controlled epidural versus intravenous analgesia in gynecologic oncology surgery. Gynecol Oncol. 2009 Dec; 115(3):357-61.
    View on PubMed
  12. Schmid S, Hsu IC, Hu JM, Sherman AE, Osann K, Kapp DS, Chan JK. Adjuvant radiation therapy in stage III node-positive uterine cancer. Gynecol Oncol. 2009 Nov; 115(2):239-43.
    View on PubMed
  13. Chan JK, Kawar NM, Shin JY, Osann K, Chen LM, Powell CB, Kapp DS. Endometrial stromal sarcoma: a population-based analysis. Br J Cancer. 2008 Oct 21; 99(8):1210-5.
    View on PubMed
  14. Sugiyama VE, Chan JK, Kapp DS. Management of melanomas of the female genital tract. Curr Opin Oncol. 2008 Sep; 20(5):565-9.
    View on PubMed
  15. Chan JK, Tewari KS, Waller S, Cheung MK, Shin JY, Osann K, Kapp DS. The influence of conservative surgical practices for malignant ovarian germ cell tumors. J Surg Oncol. 2008 Aug 1; 98(2):111-6.
    View on PubMed
  16. Chan JK, Tian C, Monk BJ, Herzog T, Kapp DS, Bell J, Young RC. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer. 2008 May 15; 112(10):2202-10.
    View on PubMed
  17. Chan JK, Teoh D, Hu JM, Shin JY, Osann K, Kapp DS. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers. Gynecol Oncol. 2008 Jun; 109(3):370-6.
    View on PubMed
  18. Chan J, Fuh K, Shin J, Cheung M, Powell C, Chen LM, Kapp D, Osann K. The treatment and outcomes of early-stage epithelial ovarian cancer: have we made any progress? Br J Cancer. 2008 Apr 8; 98(7):1191-6.
    View on PubMed
  19. Chan JK, Ueda SM, Sugiyama VE, Stave CD, Shin JY, Monk BJ, Sikic BI, Osann K, Kapp DS. Analysis of phase II studies on targeted agents and subsequent phase III trials: what are the predictors for success? J Clin Oncol. 2008 Mar 20; 26(9):1511-8.
    View on PubMed
  20. Kapp DS, Shin JY, Chan JK. Prognostic factors and survival in 1396 patients with uterine leiomyosarcomas: emphasis on impact of lymphadenectomy and oophorectomy. Cancer. 2008 Feb 15; 112(4):820-30.
    View on PubMed

Go to UCSF Profiles, powered by CTSI